Balentine LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,399 shares of the biopharmaceutical company’s stock after purchasing an additional 97 shares during the period. Balentine LLC’s […]
BI Asset Management Fondsmaeglerselskab A S cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 52.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,494 shares of the biopharmaceutical company’s stock after selling 4,978 shares during the quarter. BI […]
4,031 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Apexium Financial LP themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Kovitz Investment Group Partners LLC dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Fielder Capital Group LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Machina Capital S.A.S. Acquires 889 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com lowered shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday. Other analysts have also recently issued research reports about the stock. TD Cowen increased their price target on shares of Regeneron Pharmaceuticals from $1,020.00 to $1,030.00 and gave the stock […]
Concord Wealth Partners Has $422,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Itau Unibanco Holding S.A. grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 242 shares of the biopharmaceutical company’s stock after purchasing an additional 18 shares during […]
Itau Unibanco Holding S.A. Buys 18 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.